Rodrigues DN - Search Results

1

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.

Jin X, Ding D, Yan Y, Li H, Wang B, Ma L, Ye Z, Ma T, Wu Q, Rodrigues DN, Kohli M, Jimenez R, Wang L, Goodrich DW, de Bono J, Dong H, Wu H, Zhu R, Huang H. Jin X, et al. Among authors: rodrigues dn. Mol Cell. 2019 Jan 3;73(1):22-35.e6. doi: 10.1016/j.molcel.2018.10.034. Epub 2018 Dec 6. Mol Cell. 2019. PMID: 30527665 Free PMC article.

2

Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.

Barber LJ, Sandhu S, Chen L, Campbell J, Kozarewa I, Fenwick K, Assiotis I, Rodrigues DN, Reis Filho JS, Moreno V, Mateo J, Molife LR, De Bono J, Kaye S, Lord CJ, Ashworth A. Barber LJ, et al. Among authors: rodrigues dn. J Pathol. 2013 Feb;229(3):422-9. doi: 10.1002/path.4140. J Pathol. 2013. PMID: 23165508

3

Molecular pathology and prostate cancer therapeutics: from biology to bedside.

Rodrigues DN, Butler LM, Estelles DL, de Bono JS. Rodrigues DN, et al. J Pathol. 2014 Jan;232(2):178-84. doi: 10.1002/path.4272. J Pathol. 2014. PMID: 24108540 Review.

4

Sarcomatoid carcinoma of the prostate: ERG fluorescence in-situ hybridization confirms epithelial origin.

Rodrigues DN, Hazell S, Miranda S, Crespo M, Fisher C, de Bono JS, Attard G. Rodrigues DN, et al. Histopathology. 2015 May;66(6):898-901. doi: 10.1111/his.12493. Epub 2014 Nov 10. Histopathology. 2015. PMID: 25041380 No abstract available.

5

The promise of circulating tumor cell analysis in cancer management.

Mateo J, Gerlinger M, Rodrigues DN, de Bono JS. Mateo J, et al. Among authors: rodrigues dn. Genome Biol. 2014 Aug 30;15(8):448. doi: 10.1186/s13059-014-0448-5. Genome Biol. 2014. PMID: 25222379 Free PMC article. Review.

6

The molecular underpinnings of prostate cancer: impacts on management and pathology practice.

Rodrigues DN, Boysen G, Sumanasuriya S, Seed G, Marzo AM, de Bono J. Rodrigues DN, et al. J Pathol. 2017 Jan;241(2):173-182. doi: 10.1002/path.4826. Epub 2016 Dec 1. J Pathol. 2017. PMID: 27753448 Review.

7

Circulating biomarkers of neuroendocrine prostate cancer: an unmet challenge.

Rescigno P, Rodrigues DN, de Bono JS. Rescigno P, et al. Among authors: rodrigues dn. BJU Int. 2017 Jan;119(1):3-4. doi: 10.1111/bju.13550. BJU Int. 2017. PMID: 28000989 No abstract available.

8

Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer.

Miao L, Yang L, Li R, Rodrigues DN, Crespo M, Hsieh JT, Tilley WD, de Bono J, Selth LA, Raj GV. Miao L, et al. Among authors: rodrigues dn. Cancer Res. 2017 Jun 1;77(11):3101-3112. doi: 10.1158/0008-5472.CAN-16-2169. Epub 2017 Mar 16. Cancer Res. 2017. PMID: 28302679

9

Differential impact of RB status on E2F1 reprogramming in human cancer.

McNair C, Xu K, Mandigo AC, Benelli M, Leiby B, Rodrigues D, Lindberg J, Gronberg H, Crespo M, De Laere B, Dirix L, Visakorpi T, Li F, Feng FY, de Bono J, Demichelis F, Rubin MA, Brown M, Knudsen KE. McNair C, et al. J Clin Invest. 2018 Jan 2;128(1):341-358. doi: 10.1172/JCI93566. Epub 2017 Dec 4. J Clin Invest. 2018. PMID: 29202480 Free PMC article.

10

BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.

Li X, Baek G, Ramanand SG, Sharp A, Gao Y, Yuan W, Welti J, Rodrigues DN, Dolling D, Figueiredo I, Sumanasuriya S, Crespo M, Aslam A, Li R, Yin Y, Mukherjee B, Kanchwala M, Hughes AM, Halsey WS, Chiang CM, Xing C, Raj GV, Burma S, de Bono J, Mani RS. Li X, et al. Among authors: rodrigues dn. Cell Rep. 2018 Jan 16;22(3):796-808. doi: 10.1016/j.celrep.2017.12.078. Cell Rep. 2018. PMID: 29346775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page